Combination Immunotherapy and Autologous Stem Cell Transplantation for Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Myeloma
Related studies linked through entity extraction aliases.
Donor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological Cancers
- Status
- UNKNOWN
- Phase
- PHASE2
High-Dose Gemcitabine, Busulfan and Melphalan With Hematopoietic-Cell Support for Patients With Poor-Risk Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
PAV-trial: Plerixafor and Chemotherapy With Vinorelbine for Stem Cell Mobilization in Patients With Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Study Comparing Conventional Dose Combination RVD to High-Dose Treatment With ASCT in the Initial Myeloma up to 65 Years
- Status
- COMPLETED
- Phase
- PHASE3
Trial of ID-Specific Donor Vaccinated Lymphocyte Infusion for Patients With Myeloma Relapsing or Failing to Achieve a Complete Remission After an Allogenic Transplant
- Status
- TERMINATED
- Phase
- PHASE2
Dasatinib in Combination With Melphalan and Prednisone to Treat Relapsed and Refractory Multiple Myeloma Patients
- Status
- TERMINATED
- Phase
- PHASE2
Evaluation of the Drug Plerixafor in Combination With Chemotherapy and G-CSF for Stem Cell Collection
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide and High-Dose Melphalan
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
TMC (Topotecan, Cyclophosphamide and Melphalan) for Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy-Induced Peripheral Neuropathy Survey
- Status
- WITHDRAWN
- Phase
- N/A
Safety Study Looking at the Use of a Natural Killer Cell Line Against Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Effect of Low Dose Bortezomib on Bone Formation in Smoldering Myeloma Patients
- Status
- TERMINATED
- Phase
- PHASE2
Busulfan-fludarabine Conditioning and T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With Advanced Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Minor Histocompatibility Vaccination After Allogeneic Stem Cell Transplantation for Advanced Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Pharmacogenomic Study in Myeloma Patients Treated With Melphalan-prednisone-thalidomide or Lenalidomide-dexamethasone
- Status
- COMPLETED
- Phase
- NA
Acupuncture for Chemo-Induced Peripheral Neuropathy
- Status
- COMPLETED
- Phase
- PHASE2
Kappa-CD28 T Lymphocytes, Chronic Lymphocytic Leukemia, B-cell Lymphoma or Multiple Myeloma, CHARKALL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2